http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0966289-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32442a1761c50204a02025c8ed897f52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate | 1998-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9573be14f33a9c112660c20742ab39ed |
| publicationDate | 2003-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0966289-B1 |
| titleOfInvention | Budesonide for the treatment of cholestatic liver diseases |
| abstract | It has been surprisingly discovered that budesonide is effective for treating cholestatic liver diseases such as primary biliary cirrhosis, primary sclerosing cholangitis and auto-immune cholangitis. The invention therefore concerns the use of budesonide for treating cholestatic liver diseases. |
| priorityDate | 1997-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 531.